FORMULATING AND ENGINEERING CONFIDENCE

Vectura is now part of global medical CDMO Phillips Medisize. By combining the strengths of both companies, we enhance our ability to deliver a broader portfolio of innovative inhalation solutions to our pharmaceutical customers and to fulfill our shared vision of helping patients around the world live healthier lives.

Together, we now offer formulation, device design and combination product development, as well as manufacturing services, to support the growing global need for inhalation and nasal therapies. Our expertise spans small molecules, biologics, complex combinations and generic products for pMDI, DPI, nasal inhaler and nebulizer devices.

With our 60 years of CDMO experience and extensive global capabilities, pharmaceutical leaders collaborate with our 6,000+ scientists, engineers and experts across seven R&D innovation centers and 23 manufacturing facilities in 11 countries. Learn more by visiting our stand and www.phillipsmedisize.com.